SILO PHARMA, INC. (SILO) Operating income 2017–2025
SILO PHARMA, INC. (SILO) annual operating income history from SEC filings — each fiscal year as reported.
-$4.3MFY2025 · since FY2017: -$490,871 → -$4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.3M | +9.0% |
| FY2024 | -$4.7M | -22.0% |
| FY2023 | -$3.9M | -6.3% |
| FY2022 | -$3.6M | -32.2% |
| FY2021 | -$2.7M | -24.6% |
| FY2020 | -$2.2M | -136.6% |
| FY2019 | -$930,403 | -56.6% |
| FY2018 | -$594,242 | -21.1% |
| FY2017 | -$490,871 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SILO financial trends
SILO RevenueSILO Net incomeSILO Net marginSILO Gross profitSILO Gross marginSILO Operating marginSILO Operating cash flowSILO Free cash flowSILO Capital expendituresSILO Return on equitySILO Stock buybacksSILO Dividends paidSILO Total assetsSILO Total liabilitiesSILO Shareholders’ equitySILO overview →